NO20041387L - Fremgangsmate for fremstilling av noen halogeno-substituerte monosulfider og deres hydroksy-monosulfid eller isotiouroniumbromid ekvivalenter som mellomprodukter - Google Patents

Fremgangsmate for fremstilling av noen halogeno-substituerte monosulfider og deres hydroksy-monosulfid eller isotiouroniumbromid ekvivalenter som mellomprodukter

Info

Publication number
NO20041387L
NO20041387L NO20041387A NO20041387A NO20041387L NO 20041387 L NO20041387 L NO 20041387L NO 20041387 A NO20041387 A NO 20041387A NO 20041387 A NO20041387 A NO 20041387A NO 20041387 L NO20041387 L NO 20041387L
Authority
NO
Norway
Prior art keywords
monosulfides
monosulfide
intermediates
halo
hydroxy
Prior art date
Application number
NO20041387A
Other languages
English (en)
Other versions
NO331195B1 (no
Inventor
Kenneth Edwin Herbert Warren
Anne Margaret Lamont Kane
Original Assignee
Astrazeneca Ab Global Ip
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab Global Ip filed Critical Astrazeneca Ab Global Ip
Publication of NO20041387L publication Critical patent/NO20041387L/no
Publication of NO331195B1 publication Critical patent/NO331195B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/12Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30Isothioureas
    • C07C335/32Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20041387A 2001-10-05 2004-03-31 Fremgangsmate for fremstilling av halogen-substituerte monosulfider og deres hydroksymonosulfid-evkivalenter som mellomprodukter. NO331195B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0123961.5A GB0123961D0 (en) 2001-10-05 2001-10-05 Process and intermediates
PCT/GB2002/004478 WO2003031399A1 (en) 2001-10-05 2002-10-03 Preparation process of some halogeno-substituted monosulfides and their hydroxy-monosulfide or isothiouronium bromide equivalents as intermediates

Publications (2)

Publication Number Publication Date
NO20041387L true NO20041387L (no) 2004-03-31
NO331195B1 NO331195B1 (no) 2011-10-31

Family

ID=9923306

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041387A NO331195B1 (no) 2001-10-05 2004-03-31 Fremgangsmate for fremstilling av halogen-substituerte monosulfider og deres hydroksymonosulfid-evkivalenter som mellomprodukter.

Country Status (20)

Country Link
US (1) US7323602B2 (no)
EP (1) EP1436256B1 (no)
JP (1) JP4346440B2 (no)
KR (1) KR100937916B1 (no)
CN (1) CN100522938C (no)
AR (1) AR037098A1 (no)
AT (1) ATE519736T1 (no)
AU (1) AU2002329452B2 (no)
BR (2) BR0212982A (no)
CA (1) CA2462237C (no)
ES (1) ES2368903T3 (no)
GB (1) GB0123961D0 (no)
IL (2) IL161084A0 (no)
MX (1) MXPA04003020A (no)
MY (1) MY139404A (no)
NO (1) NO331195B1 (no)
NZ (1) NZ531943A (no)
SA (1) SA02230410B1 (no)
WO (1) WO2003031399A1 (no)
ZA (1) ZA200402470B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0025221D0 (en) 2000-10-14 2000-11-29 Astrazeneca Ab New process
US7790910B2 (en) * 2004-07-27 2010-09-07 Sicor Inc. Process for the preparation of 7α-alkylated 19-norsteroids
WO2009017802A1 (en) 2007-08-01 2009-02-05 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Nitro-fattyacid modulation of type ii diabetes
JP2011519373A (ja) 2008-05-01 2011-07-07 コンプレクザ インコーポレイテッド ビニル置換脂肪酸
EP2299997A4 (en) 2008-06-19 2012-01-11 Univ Utah Res Found USE OF NITRATED LIPIDS FOR THE TREATMENT OF SIDE EFFECTS OF TOXIC MEDICAL THERAPIES
US20140024713A1 (en) 2008-06-19 2014-01-23 University Of Utah Research Foundation Use of nitrated lipids for treatment of side effects of toxic medical therapies
CN102227441A (zh) * 2008-10-15 2011-10-26 斯索恩有限公司 制备氟维司群的方法和中间体
EP3045167A1 (en) 2009-07-31 2016-07-20 University of Pittsburgh - Of the Commonwealth System of Higher Education Keto fatty acids as anti-inflammatory agents
EP2483233A4 (en) * 2009-10-02 2013-08-14 Complexa Inc HETEROATOMA CONTAINING SUBSTITUTED FATTY ACIDS
WO2013028501A1 (en) 2011-08-19 2013-02-28 The University Of Utah Research Foundation Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
PT3865484T (pt) 2015-07-07 2024-01-30 H Lundbeck As Inibidor da pde9 com esqueleto de imidazo pirazinona para tratamento de doenças periféricas
WO2017059451A1 (en) 2015-10-02 2017-04-06 Complexa, Inc. Prevention, treatment and reversal of disease using therapeutically effective amounts of activated fatty acids
CA3100988A1 (en) 2018-05-25 2019-11-28 Imara Inc. Monohydrate and crystalline forms of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7h-imidazo[1,5-a]pyrazin-8-one
CA3110680A1 (en) 2018-08-31 2020-03-05 Imara Inc. Pde9 inhibitors for treating sickle cell disease
WO2025195993A1 (en) 2024-03-18 2025-09-25 Minakem Process for the preparation of fulvestrant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8327256D0 (en) 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
SE8705150D0 (sv) * 1987-12-23 1987-12-23 Haessle Ab Novel antiarrhythmic agents
US5552391A (en) 1990-01-16 1996-09-03 La Jolla Pharmaceutical Company Chemically-defined non-polymeric valency platform molecules and conjugates thereof
DE4132182A1 (de) * 1991-09-24 1993-03-25 Schering Ag 11(beta)-substituierte 14, 17-ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
JP2003514814A (ja) * 1999-11-12 2003-04-22 ビーエーエスエフ アクチェンゲゼルシャフト 除草剤2−アリールオキシ−6−フルオロアルキルチオアルキル(アルケニル)オキシ−ピリジン
GB0025221D0 (en) 2000-10-14 2000-11-29 Astrazeneca Ab New process

Also Published As

Publication number Publication date
AR037098A1 (es) 2004-10-20
US20050033085A1 (en) 2005-02-10
SA02230410B1 (ar) 2009-01-31
IL161084A (en) 2011-06-30
JP2005504845A (ja) 2005-02-17
CN1564812A (zh) 2005-01-12
ES2368903T3 (es) 2011-11-23
MXPA04003020A (es) 2004-07-05
ATE519736T1 (de) 2011-08-15
JP4346440B2 (ja) 2009-10-21
BR0212982A (pt) 2004-10-13
GB0123961D0 (en) 2001-11-28
CA2462237A1 (en) 2003-04-17
KR20050033507A (ko) 2005-04-12
MY139404A (en) 2009-09-30
KR100937916B1 (ko) 2010-01-21
AU2002329452B2 (en) 2009-03-12
IL161084A0 (en) 2004-08-31
ZA200402470B (en) 2005-02-23
EP1436256B1 (en) 2011-08-10
CA2462237C (en) 2012-07-03
EP1436256A1 (en) 2004-07-14
BRPI0212982B1 (pt) 2017-09-12
HK1066786A1 (en) 2005-04-01
NO331195B1 (no) 2011-10-31
US7323602B2 (en) 2008-01-29
WO2003031399A1 (en) 2003-04-17
CN100522938C (zh) 2009-08-05
NZ531943A (en) 2006-09-29

Similar Documents

Publication Publication Date Title
NO20041387L (no) Fremgangsmate for fremstilling av noen halogeno-substituerte monosulfider og deres hydroksy-monosulfid eller isotiouroniumbromid ekvivalenter som mellomprodukter
NO20035775L (no) 3-fluor-pyrrolidiner som anti-diabetesmidler
NO2012018I2 (no) Canakinumab eller direkte ekvivalenter derav
NO20033733D0 (no) Festeinnretning for sternum
NO20025488D0 (no) Stabiliserte tetrasoliumreagenssammensetninger og fremgangsmÕter for deres anvendelse
NO20025489L (no) Stabiliserte tetrasolium-fenasin-reagens-sammensetninger og fremgangsmåterfor deres anvendelse
EP1453536A4 (en) COMPOSITION FOR PRESERVING VIRUSES
DE60236569D1 (de) Siliziumoxidmembran
DK1480955T3 (da) O-cyclopropyl-carboxanilider og deres anvendelse som fungicider
DK1558615T3 (da) Purin-forbindelser og deres anvendelse som cannabinoid receptor ligander
NO20035087D0 (no) Anvendelse av HMG fragment som anti-inflammatoriske midler
NO20041887L (no) Benzomidazoler anvendelige som proteinkinase-inhibitorer
NO20041785L (no) Farmasoytisk sammensetning som innbefatter mykofenolsyre eller mykofenolatsalt
FR2830516B1 (fr) Suspension de turboreacteur
ATE391502T1 (de) Kristalline formen von fluvastatin-natrium
DK0989121T3 (da) Substituerede benzamider og deres anvendelse som immunmodulatorer
ITMI20011494A0 (it) Precedimento per la produzione di fogli di legno multilaminare
DE60213065D1 (de) Stabilisierung von getränken
NO20034434D0 (no) Indolinoner substituert i 6-stilling og deres anvendelse som kinase-inhibitorer
NO20035532D0 (no) Vannholdig sammensetning
DE60033207D1 (de) Werkzeug zur herstellung von nockenwellen durch einwalzen
ATE375961T1 (de) Reinigung von titandioxid
DE60114244D1 (de) Osteosynthesevorrichtung
EP1511864A4 (en) VIRAL CAPSIDE ASSEMBLY INTERMEDIATES
DE50203046D1 (de) Verwendung von Esterquats

Legal Events

Date Code Title Description
MK1K Patent expired